Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: Biological Effects of Quercetin in COPD [Phase 1, Phase 2]
Phase 1/2 trial evaluating biological effects of quercetin in chronic obstructive pulmonary disease; current status unknown.
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD [Phase 3]
Phase 3 trial evaluating safety and efficacy of ensifentrine in COPD has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPD [Phase 4]
Phase 4 clinical trial update evaluating nebulized heparin and salbutamol in mechanically ventilated patients with acute exacerbation of COP…
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies [Phase 2]
Phase 2 trial evaluating belimumab for emphysema patients with anti-GRP78 autoantibodies has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Health Effects of Secondhand Smoke Exposure in Outdoor Smoking Areas in Patients With COPD and Asthma ( TackSHSWP5 ) [NA]
Clinical trial studying health effects of secondhand smoke exposure in outdoor smoking areas for patients with COPD and asthma; study comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPD [Phase 3]
Phase 3 trial assessing the effects of an acute long-acting bronchodilator on oxygenation and peripheral ventilation in chronic obstructive …
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial update on the efficacy and safety of levalbuterol in chronic obstructive pulmonary disease (COPD).
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Nasal Breathing and Physical Capacity [Phase 4]
Phase 4 clinical trial update evaluating nasal breathing and physical capacity in patients with nasal obstruction and COPD.
-
FDA approval · 2023-06-23FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.)
FDA approved a supplemental application for ALBUTEROL SULFATE from Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. under an ANDA for a generic p…
-
FDA approval · 2023-06-20FDA Approved: TIOTROPIUM BROMIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic tiotropium bromide (ANDA) through an Original Application for the maintenance treatment of chron…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Prevalence of Humoral Dysfunction in Pts With Frequent Exacerbations of COPD, and the Effect of SCIgR for Prevention [Phase 2]
Phase 2 clinical trial assessing humoral dysfunction in patients with frequent COPD exacerbations and the effect of SCIgR in prevention.
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Study of Humidified Air to Improve Mucociliary Clearance (MCC) in COPD [NA]
Completed clinical trial investigating humidified air to improve mucociliary clearance in COPD; results posted in 2023.
-
FDA approval · 2023-06-06FDA Approved: ROFLUMILAST — Supplemental Application (Solco Healthcare US, LLC.)
The FDA approved a supplemental application for a generic roflumilast product from Solco Healthcare US, LLC. This approval makes a generic C…
-
FDA approval · 2023-06-02FDA Approved: UMECLIDINIUM AND VILANTEROL ELLIPTA — Supplemental Application (Prasco Laboratories)
FDA approves a supplemental application from Prasco Laboratories for UMECLIDINIUM AND VILANTEROL ELLIPTA (umeclidinium bromide and vilantero…
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Feasibility of At-Home Handheld Spirometry [NA]
A terminated feasibility study evaluating at-home handheld spirometry for COPD; results posted in 2023.
-
FDA approval · 2023-05-28FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for albuterol sulfate from Sun Pharmaceutical Industries, updating the status of this generic produc…
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Targeted AntiBiotics for Chronic Pulmonary Diseases [Phase 4]
Phase 4 clinical trial update for targeted antibiotics in chronic pulmonary diseases has been terminated.
-
FDA approval · 2023-05-12FDA Approved: BREO ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for BREO ELLIPTA submitted by GlaxoSmithKline. The approval pertains to changes to the product's lab…
-
FDA approval · 2023-05-08FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for albuterol sulfate submitted by Mylan Pharmaceuticals Inc. under ANDA214531. This action adds…
-
CLINICAL_TRIALS trial_result · 2023-05-08Clinical Trial Update: Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD [Phase 4]
Phase 4 clinical trial update evaluating peak inspiratory flow and dry powder inhaler performance in COPD.
-
CLINICAL_TRIALS withdrawal · 2023-05-06Clinical Trial Update: A Study of RYMPHYSIA for Alpha1-Proteinase Inhibitor (A1PI) Therapy in Adults With A1PI Deficiency and Chronic Obstructive Pulmonary Disease (COPD)-Emphysema [Phase 4]
Phase 4 trial of RYMPHYSIA for A1PI deficiency in adults with COPD-emphysema has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients [Phase 2]
Phase 2 dose-range finding study completed for QBW251 in COPD patients, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Effects of Spiolto® Respimat® (Tiotropium/Olodaterol) on Cardiac Function in Hyperinflated COPD Subjects [Phase 4]
Phase 4 trial assessing the effects of Spiolto Respimat (tiotropium/olodaterol) on cardiac function in hyperinflated COPD subjects has been …
-
FDA approval · 2023-04-26FDA Approved: THEOPHYLLINE — Original Application (Bionpharma Inc.,)
FDA approves Bionpharma Inc.’s Theophylline generic under an Original Application (ANDA). The product is approved for use in asthma and chro…
-
FDA approval · 2023-04-18FDA Approved: ROFLUMILAST — Original Application (Ascend Laboratories, LLC)
FDA approved an original ANDA for roflumilast from Ascend Laboratories, making a generic version of this COPD medication available.